Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937

Nutrition

Volumn 31, Issue 7-8, 2015, Pages 1031-1037

  Dasgupta, Pritha ^a   Sengupta Bandyopadhyay, Sumita ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Apoptosis; C Myc; Diallyl disulfide; HTERT; Myc nick; Sp 1; Telomerase

Indexed keywords

DIALLYL DISULFIDE; DOUBLE STRANDED DNA; MESSENGER RNA; MYC PROTEIN; ORGANOSULFUR DERIVATIVE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SP1; ALLYL COMPOUND; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; DISULFIDE; MAD1L1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PLANT EXTRACT;

ARTICLE; BINDING ASSAY; BINDING SITE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; ENZYME REGULATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LYMPHOMA; LYMPHOMA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRANSCRIPTION REGULATION; U937 CELL LINE; WESTERN BLOTTING; CHEMISTRY; DRUG EFFECTS; GARLIC; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE;

ALLYL COMPOUNDS; ANTICARCINOGENIC AGENTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DISULFIDES; DOWN-REGULATION; GARLIC; GENE EXPRESSION REGULATION; HUMANS; LYMPHOMA; NUCLEAR PROTEINS; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TELOMERASE;

EID: 84945919360     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.02.016     Document Type: Article

References (54)

1. Greider C.W. Telomere length regulation. Annu Rev Biochem 1996, 65:337-365.
2. Lingner J., Cooper J.P., Cech T.R. Telomerase and DNA end replication: no longer a lagging strand problem?. Science 1995, 269:1533-1534.
3. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795.
4. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997, 277:955-959.
5. Blackburn E.H. Telomerases. Annu Rev Biochem 1992, 61:113-129.
6. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., et al. The RNA component of human telomerase. Science 1995, 269:1236-1241.
7. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M.B., et al. A mammalian telomerase-associated protein. Science 1997, 275:973-977.
8. Holt S.E., Aisner D.L., Baur J., Tesmer V.M., Dy M., Ouellette M., et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 1999, 13:817-826.
9. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
10. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
11. Greider C.W. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A 1998, 95:90-92.
12. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 1991, 256:271-282.
13. Sui X., Kong N., Wang Z., Pan H. Epigenetic regulation of the human telomerase reverse transciptase gene: a potential therapeutic target for the treatment of leukemia (Review). Oncol Lett 2013, 6:317-322.
14. Cong Y.S., Wright W.E., Shay J.W. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002, 66:407-425.
15. Horikawa I., Cable P.L., Afshari C., Barrett J.C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 1999, 59:826-830.
16. Kyo S., Takakura M., Fujiwara T., Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 2008, 99:1528-1538.
17. Latil A., Vidaud D., Valeri A., Fournier G., Vidaud M., Lidereau R., et al. htert expression correlates with MYC overexpression in human prostate cancer. Int J Cancer 2000, 89:172-176.
18. Li L., Xiong Y.Y., Liu L., Chen T.X., Yao X.F., Wang Y.W. Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer. Ai Zheng 2005, 24:53-57.
19. Kumari A., Srinivasan R., Wig J.D. Effect of c-MYC and E2 F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreatic cancer-derived cell lines. Pancreatology 2009, 9:360-368.
20. Heeg S., Hirt N., Queisser A., Schmieg H., Thaler M., Kunert H., et al. EGFR overexpression induces activation of telomerase via PI3 K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis. Cancer Sci 2011, 102:351-360.
21. Ishibashi T., Lippard S.J. Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci U S A 1998, 95:4219-4223.
22. Mo Y., Gan Y., Song S., Johnston J., Xiao X., Wientjes M.G., et al. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res 2003, 63:579-585.
23. Multani A.S., Li C., Ozen M., Imam A.S., Wallace S., Pathak S. Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity. Oncol Rep 1999, 6:39-44.
24. Ramirez R., Carracedo J., Jimenez R., Canela A., Herrera E., Aljama P., et al. Massive telomere loss is an early event of DNA damage-induced apoptosis. J Biol Chem 2003, 278:836-842.
25. Moon D.O., Kim M.O., Lee J.D., Choi Y.H., Kim G.Y. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett 2009, 286:172-179.
26. Kim M.O., Moon D.O., Choi Y.H., Shin D.Y., Kang H.S., Choi B.T., et al. Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells. Cancer Lett 2008, 261:98-107.
27. Jo H.J., Song J.D., Kim K.M., Cho Y.H., Kim K.H., Park Y.C. Diallyl disulfide induces reversible G2/M phase arrest on a p53-independent mechanism in human colon cancer HCT-116 cells. Oncol Rep 2008, 19:275-280.
28. Knowles L.M., Milner J.A. Depressed p34 cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr Cancer 1998, 30:169-174.
29. Milner J.A. Preclinical perspectives on garlic and cancer. J Nutr 2006, 136:827S-831S.
30. Nakagawa H., Tsuta K., Kiuchi K., Senzaki H., Tanaka K., Hioki K., et al. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 2001, 22:891-897.
31. Wu X.J., Kassie F., Mersch-Sundermann V. The role of reactive oxygen species (ROS) production on diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carcinoma cells. Mutat Res 2005, 579:115-124.
32. Xiao D., Pinto J.T., Gundersen G.G., Weinstein I.B. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol Cancer Ther 2005, 4:1388-1398.
33. Dasgupta P., Bandyopadhyay S.S. Role of di-allyl disulfide, a garlic component in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines. Nutr Cancer 2013, 65:611-622.
34. De Almeida M.C., Silva A.C., Barral A., Barral Netto M. A simple method for human peripheral blood monocyte Isolation. Mem Inst Oswaldo Cruz 2000, 95:221-223.
35. Zor T., Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem 1996, 236:302-308.
36. Pandit B., Bhattacharyya N.P. Detection of telomerase activity in Chinese hamster V79 cells and its inhibition by 7-deaza-deoxy guanosine triphosphate and (TTAGGG)4 in vitro. Biochem Biophys Res Commun 1998, 251:620-624.
37. Banerjee P.P., Jagadeesh S. Non-radioactive assay methods for the assessment of telomerase activity and telomere length. Methods Mol Biol 2009, 523:383-394.
38. Wang Z., Kyo S., Takakura M., Tanaka M., Yatabe N., Maida Y., et al. Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway. Cancer Res 2000, 60:5376-5381.
39. Henderson Y.C., Breau R.L., Liu T.J., Clayman G.L. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, and E2 F-1 genes by means of recombinant adenovirus. Head Neck 2000, 22:347-354.
40. Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4 A5 cells. Biosci Biotechnol Biochem 2000, 64:1813-1820.
41. Bandyopadhyay S., Sengupta T.K., Spicer E.K. PMA induces stabilization of oncostatin M mRNA in human lymphoma U937 cells. Biochem J 2008, 410:177-186.
42. Harley C.B., Kim N.W., Prowse K.R., Weinrich S.L., Hirsch K.S., West M.D., et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994, 59:307-315.
43. Hiyama E., Gollahon L., Kataoka T., Kuroi K., Yokoyama T., Gazdar A.F., et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996, 88:116-122.
44. Tsao J., Zhao Y., Lukas J., Yang X., Shah A., Press M., et al. Telomerase activity in normal and neoplastic breast. Clin Cancer Res 1997, 3:627-631.
45. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2:764-776.
46. Fu W., Begley J.G., Killen M.W., Mattson M.P. Antiapoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 1999, 274:7264-7271.
47. Liu W.J., Jiang J.F., Xiao D., Ding J. Down-regulation of telomerase activity via protein phosphatase 2 A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem Pharmacol 2002, 64:1677-1687.
48. Conacci-Sorrell M., Ngouenet C., Eisenman R.N. Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation. Cell 2010, 142:480-493.
49. Conacci-Sorrell M., Eisenman R.N. Post-translational control of Myc function during differentiation. Cell Cycle 2011, 10:604-610.
50. Conacci-Sorrell M., Ngouenet C., Anderson S., Brabletz T., Eisenman R.N. Stress-induced cleavage of Myc promotes cancer cell survival. Genes Dev 2014, 28:689-707.
51. Karmakar S., Banik N.L., Patel S.J., Ray S.K. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5 Y cells. Apoptosis 2007, 12:671-684.
52. Das A., Banik N.L., Ray S.K. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98 G and U87 MG cells. Cancer 2007, 110:1083-1095.
53. Rickers A., Peters N., Badock V., Beyaert R., Vandenabeele P., Dörken B., et al. Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis. Eur J Biochem 1999, 261:269-274.
54. Piedrafita F.J., Pfahl M. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol 1997, 17:6348-6358.